Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICONIC: Maralixibat in Alagille Syndrome
NCT02160782Phase 2Completed
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Oct 2014
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of maralixibat in Alagille syndrome (ALGS), sponsored by Mirum Pharmaceuticals, Inc.. Started Oct 2014; status: completed.
02
Drugs
maralixibat
03
Conditions
Alagille syndrome (ALGS)
Beyond the preview
Go deeper on NCT02160782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160782.